tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ELEV Stock Latest News

Elevation Oncology Announces Preliminary Phase 1 Trial Results
Company AnnouncementsElevation Oncology Announces Preliminary Phase 1 Trial Results
1M ago
8K
ELEV
Elevation Oncology’s EO-3021 shows ‘promising’ Phase 1 anti-tumor results
PremiumThe Fly
Elevation Oncology’s EO-3021 shows ‘promising’ Phase 1 anti-tumor results
1M ago
ELEV
Elevation Oncology reports Q2 EPS (18c), consensus (22c)
PremiumThe Fly
Elevation Oncology reports Q2 EPS (18c), consensus (22c)
1M ago
ELEV
Elevation Oncology Reports Second Quarter 2024 Financial Results and Highlights Recent Business Achievements
PremiumPress Releases
Elevation Oncology Reports Second Quarter 2024 Financial Results and Highlights Recent Business Achievements
1M ago
ELEV
Elevation Oncology to evaluate combination in gastroesophageal junction cancer
PremiumThe Fly
Elevation Oncology to evaluate combination in gastroesophageal junction cancer
3M ago
GSK
LLY
Elevation Oncology initiated with an Overweight at Piper Sandler
PremiumThe FlyElevation Oncology initiated with an Overweight at Piper Sandler
4M ago
ELEV
Elevation Oncology initiated with an Overweight at Stephens
Premium
The Fly
Elevation Oncology initiated with an Overweight at Stephens
4M ago
ELEV
3 Best Stocks to Buy Now, 5/6/2024, According to Top Analysts 
Premium
Market News
3 Best Stocks to Buy Now, 5/6/2024, According to Top Analysts 
5M ago
CGON
ELEV
Elevation Oncology files to sell 3.28M shares of common stock for holders
PremiumThe Fly
Elevation Oncology files to sell 3.28M shares of common stock for holders
5M ago
ELEV
Elevation Oncology files $350M mixed securities shelf
PremiumThe Fly
Elevation Oncology files $350M mixed securities shelf
5M ago
ELEV
Elevation Oncology reports Q1 EPS (23c), consensus (20c)
PremiumThe Fly
Elevation Oncology reports Q1 EPS (23c), consensus (20c)
5M ago
ELEV
Elevation Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Achievements
PremiumPress Releases
Elevation Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Achievements
5M ago
ELEV
Elevation Oncology presents preclinical proof-of concept data for HER3-ADC
PremiumThe FlyElevation Oncology presents preclinical proof-of concept data for HER3-ADC
5M ago
ELEV
Lori Hu Resigns, Darcy Mootz Joins Elevation Oncology Board
Premium
Company Announcements
Lori Hu Resigns, Darcy Mootz Joins Elevation Oncology Board
6M ago
8K
ELEV
Four new option listings on March 20th
Premium
The Fly
Four new option listings on March 20th
6M ago
ADTH
APGE
A New Cause for Concern: Elevation Oncology, Inc. Adds a New Debt & Financing Risk
PremiumCompany Announcements
A New Cause for Concern: Elevation Oncology, Inc. Adds a New Debt & Financing Risk
7M ago
ELEV
Elevation Oncology price target raised to $8 from $5 at Wedbush
PremiumThe Fly
Elevation Oncology price target raised to $8 from $5 at Wedbush
7M ago
ELEV
Elevation Oncology reports Q4 EPS (19c), consensus (24c)
PremiumThe Fly
Elevation Oncology reports Q4 EPS (19c), consensus (24c)
7M ago
ELEV
GoodRx upgraded, Fisker downgraded: Wall Street’s top analyst calls
PremiumThe Fly
GoodRx upgraded, Fisker downgraded: Wall Street’s top analyst calls
7M ago
EL
PG
Elevation Oncology initiated with an Outperform at JMP Securities
PremiumThe FlyElevation Oncology initiated with an Outperform at JMP Securities
7M ago
ELEV
Elevation Oncology doses first patient in Japan in Phase 1 trial of EO-3021
Premium
The Fly
Elevation Oncology doses first patient in Japan in Phase 1 trial of EO-3021
7M ago
ELEV
Elevation Oncology price target raised to $6 from $1.50 at H.C. Wainwright
Premium
The Fly
Elevation Oncology price target raised to $6 from $1.50 at H.C. Wainwright
7M ago
ELEV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >